President Trump has used it as a preventative measure, and Two potential safety concerns about the use of hydroxychloroquine are heart health issues and interactions with other drugs
The efficacy and safety of Hydroxychloroquine (HCQ) in treating coronavirus disease (COVID-19) is disputed
However, clinical observations of the effects of this drug in patients with
Food and Drug Administration, July 1, 2020, FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a
Multiple
Although an independent audit of the provenance and validity
Also, hydroxychloroquine doesn't prevent infection with the virus that causes COVID-19
FILE – This Monday, April 6, 2020 file photo shows an The study said hydroxychloroquine “did not significantly improve clinical status at day 14″ among hospitalized patients with respiratory illness from COVID-19
, chloroquine [Aralen], hydroxychloroquine [Plaquenil]) can cause oral mucosa hyperpigmentation due to direct stimulation of melanocytes
Hydroxychloroquine could cause fatal heart rhythm problems, especially if you take it with another drug
You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with hydroxychloroquine
Hydroxychloroquine inhibits the action of cathepsin L in endolysosomes, but because cathepsin L cleavage is minor compared to TMPRSS2 cleavage, hydroxychloroquine does little to inhibit SARS-CoV-2 infection
The efficacy and safety of Hydroxychloroquine (HCQ) in treating coronavirus disease (COVID-19) is disputed
WASHINGTON – Dr